Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
As the prevalence of obesity rises, so do related chronic conditions such as diabetes, heart disease and hypertension, creating a massive market for treatments like GLP-1 drugs
10.1152/ajpendo.90887.2008 39
By blocking SGLT-2, a reduced PDA risk was found in SGLT-2 inhibitor users, and a decreased cancer proliferation in preclinical pancreatic cancer models when treated with SGLT-2 inhibitor (Dicembrini et al., 2019
229 REWIND (around 9,900 participants, approximately one third with established CVD, median 5.4 years) demonstrated dulaglutide lowered major adverse cardiovascular event risk compared with placebo (HR 0.88
~3367.9 Da
Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: a signature step hinting towards clinical perfection
US$ 22.91
US$ 20.80
US$ 25.86
US$ 23.86
US$ 21.58
US$ 26.90
US$ 22.24
